T-CAR cell-directed immunotherapy for the treatment of acute lymphoid leukemia. Research, Society and Development, [S. l.], v. 9, n. 11, p. e72891110372, 2020. DOI: 10.33448/rsd-v9i11.10372. Disponível em: https://www.rsdjournal.org/rsd/article/view/10372. Acesso em: 17 dec. 2025.